ArticleJournal for immunotherapy of cancer2024

Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma.

Wei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.